基于超声指征的侵入性产前诊断的人群趋势:1994至2016年二十年间的变化
该研究回顾性分析了澳大利亚维多利亚州1994至2016年间所有基于超声指征的侵入性产前诊断操作,共记录1 533 317例出生和16 152例以超声异常为主要指征的诊断操作。近年来超声异常成为产前侵入性检测最常见指征(2013至2016年间占29.4%),2016年超过95%的超声指征操作采用染色体微阵列分析(CMA),其中致病性拷贝数变异(CNV)最常见(3.5%),其次为21三体(2.8%)。16周前超声指征检测的诊断率显著高于20周后(31.5% vs 9.0%)。
要点
- 超声异常已成为产前侵入性检测最常见指征,2013至2016年间占29.4%。
- 2016年超过95%的超声指征操作采用CMA,致病性CNV最常见(3.5%),其次为21三体(2.8%)。
- 16周前超声指征检测诊断率显著高于20周后(31.5% vs 9.0%)。
核心结论
- 在基因组时代,超声指征的侵入性检测正以新的方式贡献于产前诊断。
- 致病性CNV现已成为超声指征检测后最可能的诊断,而非21三体或其他整倍体异常。
- 尽管早孕期非整倍体筛查稳步改进,20周后超声指征检测的诊断率因CMA使用增加而保持稳定。
- 16周前因结构异常进行的操作继续具有最高诊断率,支持在11-13周进行早期胎儿结构评估的益处。
研究设计与样本
- 回顾性分析1994至2016年间澳大利亚维多利亚州所有基于超声指征的侵入性产前诊断操作(羊膜腔穿刺和绒毛膜绒毛取样)。
- 研究期间共记录1 533 317例出生和16 152例以超声异常为主要指征的诊断操作。
- 收集母亲年龄、检测指征、诊断操作类型、孕龄、染色体分析类型(G显带核型分析或CMA)及检测结果。
- 诊断率按年份、母亲年龄和孕龄分析,统计分析采用χ2趋势检验或比例差异检验。
主要发现
- 近年来超声异常成为产前侵入性检测最常见指征,2013至2016年间占诊断检测的29.4%。
- 2016年超过95%的超声指征操作采用CMA,其中致病性CNV最常见(3.5%),其次为21三体(2.8%)。
- 16周前超声指征检测的诊断率显著高于20周后(31.5% vs 9.0%)。
关键数值与推荐
- 超声检测指征包括:胎儿结构异常、胎儿死亡、胎儿生长受限、羊水量异常、遗传性「软指标」及未明确的超声异常。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess trends in ultrasound-indicated prenatal diagnostic testing performed over the past two decades in the Australian state of Victoria, in the context of rapidly changing practices in aneuploidy screening and chromosome analysis. METHODS: This was a retrospective analysis of all ultrasound-indicated prenatal diagnostic testing (amniocentesis and chorionic villus sampling) performed in the state of Victoria between 1994 and 2016. Ultrasound indications for testing included: fetal structural abnormality, fetal death, fetal growth restriction, abnormal amniotic fluid volume, genetic 'soft marker' and unspecified ultrasound abnormality. Maternal age, indication for testing, type of diagnostic procedure, gestational age, type of chromosome analysis (G-banded karyotyping or chromosomal microarray (CMA)) and test results were obtained. Diagnostic yield (i.e. percentage of tests yielding a major abnormality) was analyzed by year, maternal age and gestational age. Statistical analysis was performed using the χ2 tests for trend or difference in proportions, as appropriate. RESULTS: During the 23-year study period, 1 533 317 births were recorded and 16 152 diagnostic procedures were performed for the primary indication of ultrasound abnormality. In recent years, ultrasound abnormality became the most common indication for prenatal invasive testing (29.4% of diagnostic tests between 2013 and 2016) due to a steep decline in testing for other indications such as positive result on combined first-trimester screening or advanced maternal age alone. In 2016, over 95% of ultrasound-indicated procedures were performed with CMA; among these, pathogenic copy number variant (CNV) was the most common (3.5%) abnormality detected, followed by trisomy 21 (2.8%). The diagnostic yield of ultrasound-indicated tests performed < 16 weeks was significantly higher than that of tests performed after 20 weeks (31.5% vs 9.0%). CONCLUSIONS: Ultrasound-indicated invasive testing is contributing to prenatal diagnosis in new ways in the genomic era. A pathogenic CNV is now the most likely diagnosis after ultrasound-indicated testing, rather than trisomy 21 or other whole-chromosome aneuploidy. Despite steady improvements in first-trimester screening for aneuploidy, the diagnostic yield of ultrasound-indicated tests > 20 weeks has remained stable due to increased utilization of CMA. Procedures performed for structural abnormalities < 16 weeks continue to have the highest diagnostic yield, supporting the benefits of early fetal structural assessment at 11-13 weeks. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Lostchuck E, Poulton A, Halliday J, et al. Population-based trends in invasive prenatal diagnosis for ultrasound-based indications: two decades of change from 1994 to 2016. Ultrasound Obstet Gynecol. 2019. PMID: 29877030. doi:10.1002/uog.19107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。